| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000318750 |
| P953 | full work available at URL | https://karger.com/dem/article-pdf/30/1/71/2567359/000318750.pdf |
| https://www.karger.com/Article/Pdf/318750 | ||
| P698 | PubMed publication ID | 20689286 |
| P2093 | author name string | Ichiro Akiguchi | |
| Toshiyuki Watanabe | |||
| Akihiko Shiino | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| mild cognitive impairment | Q1472703 | ||
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 71-77 | |
| P577 | publication date | 2010-08-05 | |
| P1433 | published in | Dementia and Geriatric Cognitive Disorders | Q15749436 |
| P1476 | title | Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging | |
| Absolute Quantification in Proton Magnetic Resonance Spectroscopy Is Useful to Differentiate Amnesic Mild Cognitive Impairment from Alzheimer’s Disease and Healthy Aging | |||
| P478 | volume | 30 |
| Q42620801 | A guanidine-appended scyllo-inositol derivative AAD-66 enhances brain delivery and ameliorates Alzheimer's phenotypes |
| Q30770751 | Advances in high-field magnetic resonance spectroscopy in Alzheimer's disease |
| Q42103589 | An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease |
| Q48219698 | Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB-PET Study |
| Q44937365 | Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study |
| Q64103437 | Distinctive Neurochemistry in Alzheimer's Disease via 7 T In Vivo Magnetic Resonance Spectroscopy |
| Q51176116 | Early differences in dorsal hippocampal metabolite levels in males but not females in a transgenic rat model of Alzheimer's disease. |
| Q48396275 | Glutamate-glutamine and GABA in brain of normal aged and patients with cognitive impairment |
| Q50984899 | Hippocampal integrity and neurocognition in first-episode schizophrenia: a multidimensional study. |
| Q58588635 | In vivo Molecular Imaging of Neuroinflammation in Alzheimer's disease |
| Q48327909 | Longitudinal investigation of neuroinflammation and metabolite profiles in the APPswe ×PS1Δe9 transgenic mouse model of Alzheimer's disease |
| Q42655692 | Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses |
| Q30996805 | Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis |
| Q26999015 | Metabolic disturbances in diseases with neurological involvement |
| Q38461379 | Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy |
| Q37618970 | Motor and premotor cortices in subcortical stroke: proton magnetic resonance spectroscopy measures and arm motor impairment. |
| Q36765774 | Neuronal-glial alterations in non-primary motor areas in chronic subcortical stroke |
| Q33993466 | Other magnetic resonance imaging techniques |
| Q49074225 | Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study |
| Q30803093 | Various MRS application tools for Alzheimer disease and mild cognitive impairment |
Search more.